Medpage Today on MSN1d
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression Risk
Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Science Daily1d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
Which diabetes drugs are linked to the lowest depression risk?
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
HealthDay on MSN20h
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
FoodNavigator1d
Is this GLP-1.2? New generation of weight-loss drugs moving in
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
GLP-1 receptor agonists could hold promise for opioid use disorder treatment
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...
Medscape16h
GLP-1 Drugs Cut Glaucoma Risk in Nondiabetic Obesity
GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...
BMJ11h
GLP-1 agonists: 82 deaths linked to adverse reactions, UK data show
Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. Data from the ...
GLP-1 drugs may aid brain health, but do they bring other risks?
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...